Indeed, genes related to the cell cycle (CDKN2A, RB1, NFE2L2, CHEK1, and CHEK2) have been found to contain mutations in 2–10% of ESCC cases [24]. This evidence concerns the gene CHEK2 and esophageal squamous cell carcinoma.